Free Trial

Clearmind Medicine (CMND) SEC Filings & 10K Form

Clearmind Medicine logo
$1.07 +0.02 (+1.90%)
Closing price 03/28/2025 03:53 PM Eastern
Extended Trading
$1.06 -0.01 (-0.47%)
As of 03/28/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Clearmind Medicine SEC Filings

DateFilerForm TypeView
03/24/2025
5:05 AM
Clearmind Medicine (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2025
11:15 PM
Clearmind Medicine (Filer)
Form EFFECT
02/18/2025
11:15 PM
Clearmind Medicine (Filer)
Form EFFECT
02/14/2025
12:27 PM
Clearmind Medicine (Subject)
Iroquois Capital Management, LLC (Filed by)
Form SCHEDULE 13G/A
02/04/2025
3:01 PM
Clearmind Medicine (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2025
3:30 PM
Clearmind Medicine (Filer)
Form POS AM
01/07/2025
3:00 PM
Clearmind Medicine (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/09/2024
4:12 PM
Clearmind Medicine (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/06/2024
4:00 PM
Clearmind Medicine (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
11:15 PM
Clearmind Medicine (Filer)
Form EFFECT
09/24/2024
3:30 PM
Clearmind Medicine (Filer)
Form POS AM
09/12/2024
3:01 PM
Clearmind Medicine (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/29/2024
3:30 PM
Clearmind Medicine (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/20/2024
3:15 PM
Clearmind Medicine (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2024
11:15 PM
Clearmind Medicine (Filer)
Form EFFECT
07/23/2024
3:15 PM
Clearmind Medicine (Filer)
Form POS AM
06/13/2024
3:01 PM
Clearmind Medicine (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/13/2024
3:01 PM
Clearmind Medicine (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
3:16 PM
Clearmind Medicine (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:CMND) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners